Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

EDWARDS LIFESCIENCES CORPORATION

(EW)
  Report
Delayed Nyse  -  04:00 2022-09-28 pm EDT
84.24 USD   +2.27%
09/23Insider Sell: Edwards Lifesciences
MT
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/22Truist Securities Lowers Price Target on Edwards Lifesciences to $112 From $117, Keeps Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Reports Q2 EPS $0.63

07/28/2022 | 04:20pm EDT


© MT Newswires 2022
All news about EDWARDS LIFESCIENCES CORPORATION
09/23Insider Sell: Edwards Lifesciences
MT
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/22Truist Securities Lowers Price Target on Edwards Lifesciences to $112 From $117, Keeps ..
MT
09/19Oppenheimer Adjusts Edwards Lifesciences' Price Target to $128 From $135, Maintains Out..
MT
09/17Edwards announces six-month data confirming teer as safe and effective for dmr in first..
PR
09/17Edwards Lifesciences Corporation Announces Results from CLASP IID
CI
09/15Edwards Lifesciences Gets FDA Approval for Pascal Precision Transcatheter Valve Repair ..
MT
09/15Edwards Lifesciences Corporation's Transcatheter Edge-To-Edge Repair Receives FDA Appro..
CI
09/15Edwards pascal precision transcatheter valve repair system receives fda approval for de..
PR
09/15Edwards Lifesciences Gets FDA Approval for Pascal Valve Repair System
DJ
More news
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2022 5 471 M - -
Net income 2022 1 542 M - -
Net cash 2022 1 264 M - -
P/E ratio 2022 34,0x
Yield 2022 -
Capitalization 51 065 M 51 065 M -
EV / Sales 2022 9,10x
EV / Sales 2023 8,02x
Nbr of Employees 15 700
Free-Float 95,3%
Chart EDWARDS LIFESCIENCES CORPORATION
Duration : Period :
Edwards Lifesciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 84,24 $
Average target price 115,65 $
Spread / Average Target 37,3%
EPS Revisions
Managers and Directors
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Todd J. Brinton Chief Scientific Officer & VP-Advanced Technology
Nicholas J. Valeriani Independent Director
Kieran Thomas Gallahue Independent Director
Sector and Competitors